Crossmark

Olverembatinib inhibits SARS‐CoV‐2‐Omicron variant‐mediated cytokine release in human peripheral blood mononuclear cells

Published Online: 2022-05-17

Published Print: 2022-06-08

Authors

Chan, Marina

Holland, Eric C

Gujral, Taranjit S https://orcid.org/0000-0002-4453-3031
Funding

Funding for this research was provided by:

Foundation for Rural Education and Development
License Information

Version of Record valid from 2022-05-17
More Information

Publication History

Received: 2022-02-19

Accepted: 2022-04-19

Published: 2022-05-17

Document is current